Your SlideShare is downloading. ×
0
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Thyroid disease in pregnancy
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Thyroid disease in pregnancy

488

Published on

Thyroid disease in pregnancy

Thyroid disease in pregnancy

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
488
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
43
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Thyroid Disease in Pregnancy Abdelrahman Al-daqqa
  • 2. Physiologic Changes in Thyroid Function During Pregnancy  Thyroid binding globulin (TBG) increases due to reduced hepatic clearance and estrogenic stimulation of TBG synthesis  The test results that change in pregnancy are influenced by changes in TBG concentration  Plasma iodide levels decrease due to fetal iodide use and increased maternal clearance -> leads to notable increase in gland size in 15% of women (without abnormal TFTs)
  • 3. Physiologic Changes in Thyroid Function During Pregnancy Maternal Status TSH **initial screening test** Free T4 Free Thyroxine Index (FTI) Total T4 Total T3 Resin Triiodo- thyronine Uptake (RT3U) Pregnancy No change No change No change Increase Increase Decrease Hyperthyroidism Decrease Increase Increase Increase Increase or no change Increase Hypothyroidism Increase Decrease Decrease Decrease Decrease or no change Decrease
  • 4. The Fetal Thyroid  Begins concentrating iodine at 10- 12 weeks  Controlled by pituitary TSH by approximately 20 weeks
  • 5. Hyperthyroidism  Occurs in 0.2% of pregnancies; Graves’ disease accounts for 95% of cases Look for: -Nervousness -Tremor -Tachycardia -Frequent stools -Sweating -Heat intolerance -Weight loss -Goiter -Insomnia -Palpitations -Hypertension -Lid lag/lid retraction -Pretibial myxedema
  • 6. Fetal & Neonatal Effects of Hyperthyroidism  Associated with preterm delivery, low birth weight, fetal loss  Fetal thyrotoxicosis (related to disease itself or treatment)  Risk of immune-mediated hypo/hyperthyroidism (due to antibodies crossing the placenta, esp. in Graves or chronic autoimmune thyroiditis)  Antibodies in Graves’ disease can be either stimulatory or inhibitory  Neonates of women with Graves’ who have been surgically/radioactively treated are at higher risk, b/c not taking suppression
  • 7. Causes & Diagnosis of Hyperthyroidism  Most common cause of hyperthyroidism is Graves’ disease  Document elevated FT4 or elevated FTI with suppressed TSH, in absence of goiter/mass  Most patients have antibodies to TSH receptor, antimicrosomal, or antithyroid peroxidase antibodies, but measurement of these is not required (though some endocrinologists recommend measuring TSI, which are stimulatory antibodies to TSH receptor)  Other causes:  Excess TSH production, gestational trophoplastic disease, hyperfunctioning thyroid adenoma, toxic goiter, subacute thyroiditis, extrathyroid source of TH
  • 8. Treatment of Hyperthyroidism  Goal is to maintain FT4/FTI in high normal range using lowest possible dose (minimize fetal exposure)  Measure FT4/FTI q2-4 weeks and titrate  Thioamides (PTU/methimazole) -> decrease thyroid hormone synthesis by blocking organification of iodide  PTU also reduces T4->T3 and may work more quickly  PTU traditionally preferred (older studies found that methimazole crossed placenta more readily and was associated with fetal aplasia cutis; newer studies refute this)
  • 9. Treatment of Hyperthyroidism  Effect of treatment on fetal thyroid function:  Possible transient suppression of thyroid function  Fetal goiter associated with Graves’ (usually drug-induced fetal hypothyroidism)  Fetal thyrotoxicosis due to maternal antibodies is rare -> screen for growth and normal FHR  Neonate at risk for thyroid dysfunction; notify pediatrician  Breastfeeding safe when taking PTU/methimazole
  • 10. Treatment of Hyperthyroidism  Beta-blockers can be used for symptomatic relief (usually Propanolol)  Reserve thyroidectomy for women in whom thioamide treatment unsuccessful  Iodine 131 contraindicated (risk of fetal thyroid ablation especially if exposed after 10 weeks); avoid pregnancy/breastfeeding for 4 months after radioactive ablation
  • 11. Hypothyroidism  Symptoms: fatigue, constipation, cold intolerance, muscle cramps, hair loss, dry skin, slow reflexes, weight gain, intellectual slowness, voice changes, insomnia  Can progress to myxedema and coma  Subclinical hypothyroidism: elevated TSH, normal FTI in asymptomatic patient  Associated with other autoimmune disorders  Type 1 DM -> 5-8% risk of hypothyroidism; 25% postpartum thyroid dysfunction
  • 12. Hypothyroidism: Fetal & Neonatal Effects  Higher incidence of LBW (due to medically indicated preterm delivery, pre-eclampsia, abruption)  Iodine deficient hypothyroidism -> congenital cretinism (growth failure, mental retardation, other neuropsychological deficits)
  • 13. Causes & Diagnosis of Hypothyroidism  Causes:  Hashimoto’s (chronic thyroiditis; most common in developed countries) & iodine deficiency -> both associated with goiter  Subacute thyroiditis -> not associated with goiter  Thyroidectomy, radioactive iodine treatment  Iodine deficiency (most common worldwide; rare in US)
  • 14. Treatment of Hypothyroidism  Treat with Levothyroxine in sufficient dose to return TSH to normal  Adjust dosage every 4 weeks  Check TSH every trimester
  • 15. ACOG Recommendations  Screening of all pregnant women with a personal history, physical examination, or symptoms of a thyroid disorder.
  • 16. Rheumatoid Arthritis
  • 17. Rheumatoid Arthritis in Pregnancy Affects 1-2% of the general population More common in women RA in pregnancy is a common challenge Sex hormones have effects on disease activity 70-80% of cases improve during pregnancy Post-partum flare common
  • 18. Minimal effects on fetal morbidity and mortality Steroids may increase risk of IUGR and PPROM Active disease correlates with lower birth weights Effect of Pregnancy on RA
  • 19. Avoid NSAIDS and high dose aspirin Low-dose aspirin safe Use lowest doses of prednisone Sulfasalazine, hydroxychloroquine in refractory cases Treatment of RA in Pregnancy
  • 20. Aspirin Azathioprine Cyclosporin Cyclophosphamide Methotrexate Chlorambucil High dose prednisone RA Medications and Breast-feeding – Avoid:
  • 21. Immune Thrombocytopenic Purpura ITP
  • 22. Immune thrombocytopenic purpura (ITP)  is a clinical syndrome in which a decreased number of circulating platelets (thrombocytopenia) manifests as a  bleeding tendency,  easy bruising (purpura), or extravasation of blood from capillaries into skin and mucous membranes (petechiae). Although most cases of acute ITP, particularly in children, are mild and self-limited, intracranial hemorrhage may occur when the platelet count drops below 10 × 109/L (< 10 × 103/µL);[1] this occurs in 0.5-1% of children, and half of these cases are fatal.[2]
  • 23. Isolated thrombocytopenia No drugs or other conditions that may affect platelet count Exclude HIV, Hep C, SLE ITP – Diagnostic Criteria:
  • 24. Increased platelet destruction Inhibition of platelet production at megakaryocyte level Mediated by IgG Abs against platelet membrane glycoproteins Usually a chronic condition ITP – Pathology:
  • 25. Petechiae, purpura, easy bruising Epistaxis, menorrhagia, bleeding from gums GIT bleeding, hematuria: rare Intracranial hemorrhage – very rare ITP – Clinical Features:
  • 26. May affect fetus in up to 15% of cases Neonatal count may drop sharply several days after birth Difficult to differentiate from gestational thrombocytopenia Epidurals safe if count > 50000 Prednisone +/- IVIG if count < 50000 Manage delivery according to standard obstetric practice Avoid NSAIDS post-partum ITP and Pregnancy
  • 27. Incidence about 5% Occurs late in pregnancy Mild (>70 000) No fetal neonatal thrombocytopenia Postpartum resolution Gestational Thrombocytopenia
  • 28. Myasthenia Gravis
  • 29. Typically presents with fluctuating skeletal muscular weakness May be ocular or generalised May have antibodies to the AChR 10-15% have a thymoma Respiratory muscle involvement may lead to respiratory failure Myasthenia Gravis:
  • 30. Pregnancy has a variable effect on the course of MG Post-partum exacerbations in 30% Infections can trigger exacerbations Steroids can cause transient worsening MgSO4 is contraindicated Myasthenia Gravis in Pregnancy:
  • 31. Transplacental passage of IgG anti-AChR Neuromuscular junction disorders Transient neonatal MG in 10-20% Decreased FM’s and breathing Polyhydramnios Arthrogryposis multiplex congenita Myasthenia Gravis – Effect on the Fetus
  • 32. First stage of labour not affected Second stage: expulsive efforts may weaken Assisted vaginal delivery may be indicated Pre-labour anaesthetic assessment indicated Myasthenia Gravis – Labour & Delivery
  • 33. Systemic Lupus Erythematosus
  • 34. Severe pulmonary hypertension Restrictive lung disease Heart failure History of severe HELLP or PET Stroke within previous 6/12 Lupus flare within previous 6/12 SLE features associated with high maternal and fetal risks – pregnancy relatively contraindicated
  • 35. Disease exacerbation Miscarriage, stillbirth IUGR, preterm labour Neonatal lupus Drugs and breast-feeding SLE complications in pregnancy:
  • 36. Occurs in up to 2% of mothers with SLE Targets skin and cardiac tissue,rarely other tissues Congenital partial or complete heart block Heart block detected in utero Complete heart block: PNM of 44% Rash: erythematous annular lesions Rash clears within 6/12 Maternal dexamethasone may prevent progression of heart block Neonatal pacemaker if HR<55 Neonatal Lupus:

×